Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trial

por Ali, Shaukat, Shalim, Elisha, Farhan, Farah, Anjum, Fatima, Ali, Ayesha, Uddin, Syed Muneeb, Shahab, Faisal, Haider, Mustafa, Ahmed, Iqra, Ali, Mir Rashid, Khan, Sadaf, Rao, Sadia, Guriro, Kabeer, Elahi, Saud, Ali, Muhammad, Mushtaq, Tehreem, Sayeed, Muneeba Ahsan, Muhaymin, Sheikh Muhammad, Luxmi, Shoba, Saifullah, Qureshi, Saeed
Publicado 2022

Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial

por Ali, Shaukat, Uddin, Syed Muneeb, Shalim, Elisha, Sayeed, Muneeba Ahsan, Anjum, Fatima, Saleem, Farah, Muhaymin, Sheikh Muhammad, Ali, Ayesha, Ali, Mir Rashid, Ahmed, Iqra, Mushtaq, Tehreem, Khan, Sadaf, Shahab, Faisal, Luxmi, Shobha, Kumar, Suneel, Arain, Habiba, Khan, Mujtaba, Khan, Abdul Samad, Mehmood, Hamid, Rasheed, Abdur, Jahangeer, Ashraf, Baig, SaifUllah, Quraishy, Saeed
Publicado 2021